Auditory hallucination and agitation due to memantine in a patient with Alzheimer's disease

a case report

Seishi Terada, Yosuke Uchitomi

Research output: Contribution to journalArticle

Abstract

Memantine is a noncompetitive N-methyl-d-aspartate receptor antagonist that is well tolerated. However, dementia patients presenting with confusion or worsening of visual hallucinations with memantine treatment have been reported. In this report, we describe an Alzheimer's disease patient presenting with severe auditory hallucination with memantine treatment.

Original languageEnglish
JournalGeneral Hospital Psychiatry
DOIs
Publication statusPublished - 2012

Fingerprint

Memantine
Hallucinations
Alzheimer Disease
Confusion
Dementia
Therapeutics

Keywords

  • Agitation
  • Alzheimer's disease (AD)
  • Auditory hallucination
  • Memantine

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{91f6c5ab7a9f421eb22e51e639dc5659,
title = "Auditory hallucination and agitation due to memantine in a patient with Alzheimer's disease: a case report",
abstract = "Memantine is a noncompetitive N-methyl-d-aspartate receptor antagonist that is well tolerated. However, dementia patients presenting with confusion or worsening of visual hallucinations with memantine treatment have been reported. In this report, we describe an Alzheimer's disease patient presenting with severe auditory hallucination with memantine treatment.",
keywords = "Agitation, Alzheimer's disease (AD), Auditory hallucination, Memantine",
author = "Seishi Terada and Yosuke Uchitomi",
year = "2012",
doi = "10.1016/j.genhosppsych.2011.11.007",
language = "English",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Auditory hallucination and agitation due to memantine in a patient with Alzheimer's disease

T2 - a case report

AU - Terada, Seishi

AU - Uchitomi, Yosuke

PY - 2012

Y1 - 2012

N2 - Memantine is a noncompetitive N-methyl-d-aspartate receptor antagonist that is well tolerated. However, dementia patients presenting with confusion or worsening of visual hallucinations with memantine treatment have been reported. In this report, we describe an Alzheimer's disease patient presenting with severe auditory hallucination with memantine treatment.

AB - Memantine is a noncompetitive N-methyl-d-aspartate receptor antagonist that is well tolerated. However, dementia patients presenting with confusion or worsening of visual hallucinations with memantine treatment have been reported. In this report, we describe an Alzheimer's disease patient presenting with severe auditory hallucination with memantine treatment.

KW - Agitation

KW - Alzheimer's disease (AD)

KW - Auditory hallucination

KW - Memantine

UR - http://www.scopus.com/inward/record.url?scp=84855584821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855584821&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2011.11.007

DO - 10.1016/j.genhosppsych.2011.11.007

M3 - Article

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

ER -